The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.
The FDA issued notices for certain migraine, acetaminophen, clonazepam, and semaglutide products.
Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.
A mix-up between 30 mg and 60 mg tablets could cause severe adverse events.
A previous gastrointestinal drug recall expands, while a new recall for an anxiety drug is issued.
Indicated for various gastrointestinal concerns, these recalls could impact certain workers’ comp patients.
Kratom continues to grow in popularity as a drug for pain and opioid withdrawal, despite concerns from the FDA, CDC and DEA.
Senna Laxative bottles were found to contain NSAIDs, while 55 lots of compounded drugs face questionable sterility.
